Exostoses, Multiple Hereditary clinical trials at UCSF
1 research study open to eligible people
open to eligible people ages 2-14
This is a randomized, double-blind, placebo-controlled study comparing the safety and efficacy of 2 dosage regimens of palovarotene versus placebo in preventing disease progression in pediatric subjects with multiple osteochondromas (MO).
San Francisco, California and other locations